RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
586. López G, Ruiz JC: Exploración vascular renal. En: Hernando
L, Aljama P, Arias M, Caramelo C, Ejido J, Lamas S, eds.
Nefrología Clínica. Madrid: Editorial Médica Panamericana,
139-144, 2003.
587. Rundback JH, Sacks D, Kent C, Cooper C, Jones D, Murphy
T, y cols. Guidelines for the reporting of renal artery revascularization
in clinical trial. AHA Scientific Statement.
Circulation 106; 1572-1585, 2002.
588. Vasbinder GBC, Nelemans PJ, Kessels AGH, Kroon AA, de
Leeuw PW, van Engelshoven JMA: Diagnostic tests for renal
artery stenosis in patients suspected of having renovascular
hypertension: a meta-analysis. Ann Intern Med 135: 401-
411, 2001.
589. Plouin PF: Stable patients with atherosclerotic renal artery
stenosis should be treated first with medical management.
Pro. Am J Kidney Dis 42: 851-857, 2003.
590. Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW,
Cantwell-Gab K, y cols. Risk of atrophy in kidneys with atherosclerotic
renal artery stenosis. Kidney Int 53: 735-742,
1998.
591. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P:
Increased cardiovascular mortality in hypertensive patients
with renal artery stenosis. Relation to sympathetic activation,
renal function and treatment regimens. J Hypertens 17:
1743-1750, 1999.
592. Kennedy DJ, Colyer WR, Brewster PS, Ankenbrandt M,
Burket MW, Nemeth AS, y cols. Renal insufficiency as a predictor
of adverse events and mortality after renal artery stent
placement. Am J Kidney Dis 42; 926-935, 2003.
593. Textor SC: Stable patients with atherosclerotic renal artery
stenosis should be treated first with medical management.
Con. Am J Kidney Dis 42: 858-863, 2003.
594. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R,
Isles CG, y cols. Randomised comparison of percutaneous
angioplasty vs continued medical therapy for hypertensive
patients with atheromatous renal artery stenosis. Scottish
and Newcastle Renal Artery Stenosis Collaborative Group. J
Hum Hypertens 12: 329-335, 1998.
595. Plouin PF, Chatellier G, Darne B, Raynaud A: Blood pressure
outcome of angioplasty in atherosclerotic renal artery stenosis
: a randomized trial. Essai Multicentrique Medicaments
vs Angioplastie (EMMA) Study Group. Hypertension 31:
823-829, 1998.
596. van de Ven PJG, Kaatee R, Beutler JJ, Beek FJA, Woittiez AJJ,
Buskens E, y cols. Arterial stenting and balloon angioplasty
in ostial atherosclerotic renovascular disease: a randomised
trial. Lancet 353: 282-286, 1999.
597. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH,
Deinum J, Postma CT, y cols. The effect of balloon angioplasty
on hypertension in atherosclerotic renal-artery stenosis.
Dutch Renal Asrtery Stenosis Intervention Cooperative
Study Group. N Engl J Med 342: 1007-1014, 2000.
598. Ives NJ, Wheatley K, Stowe RL, Krijnen P, Plouin PF, van
Jaarsveld BC, y cols. Continuing uncertainty about the value
of percutaneous revascularization in atherosclerotic renovascular
disease: a meta-analysis of randomized trials.
Nephrol Dial Transplant 18: 298-304, 2003.
599. Zuccala A, Zucchelli P: Atherosclerotic renal artery stenosis:
when is intervention by PTA or surgery justified? Nephrol
Dial Transplant 10: 585-600, 1995.
600. Navarro-Antolín J, Orte L: Enfermedad renal isquémica e
hipertensión. Hipertensión 13: 132-144, 1996.
601. Ritz E, Mann JFE: Renal angioplasty for lowering blood pressure.
N Engl J Med 342: 1042-1043, 2000.
602. Plouin PF, Rossignol P, Bobrie G: Atherosclerotic renal artery
stenosis: to treat conservatively, to dilate, to stent, or to operate?
J Am Soc Nephrol 12: 2190-2196, 2001.
603. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs
JP, y cols. for the African American Study of Kidney Disease
and Hypertension Study Group: Effect of ramipril vs amlodipine
on renal outcomes in hypertensive nephrosclerosis. A
randomised controlled trial. JAMA 285: 2719-2728, 2001.
604. Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ,
Charleston J, y cols. for the African American Study of
Kidney Disease and Hypertension Study Group: Effect of
blood pressure lowering and antihypertensive drug class on
progression of hypertensive kidney disease. JAMA 288:
2421-2431, 2002.
605. Segura J, Campo C, Rodicio JL, Ruilope LM: ACE inhibitors
and appearance of renal events in hypertensive nephrosclerosis.
Hypertension 38 (3 Pt 2): 645-649; 2001.
606. Valderrábano F, Gómez-Campderá F, Jones EH: Hipertensión
as cause of end-stage renal disease: lessons from international
registries. Kidney Int 68 (suppl): S60-S66, 1998.
607. Vikse BE, Aasarød K, Bostad L, Iversen BM: Clinical prognostic
factors in biopsy-proven benign nephrosclerosis. Nephrol
Dial Transplant 18: 517-523, 2003.
608. Textor SC. Ischemic nephropathy. Where are we now. J Am
Soc Nephrol 15: 1974-1982, 2004
609. Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN,
O´Donoghue DJ, y cols. Epidemiology of renal dysfunction
and patient outcome in atherosclerotic renal artery occlusion.
J Am Soc Nephrol 13:149-157, 2002.
610. US RENAL Data System: USRDS 2001. Annual Data Report:
The National Institutes of Health , National institute of
Diabetes and Digestive and Kidney Disease, Bethesda. MD
2001
611. Obrador CG, Ruthazer R, Arora P, Kausz AT, Pereira BJ.
Prevalence of and factors associated with suboptimal care
before initiation of dialysis in the United States. J Am Soc
Nephrol 10:1793-1800, 1999.
612. Coresh J, Weis GL, McQuillan G, Brancati FL, Levey AS,
Jones C y cols. Prevalence of high blood pressure and elevated
serum creatinine level in the United States : findings from
the third National Health and Nutrition Examination Survey
(1998-1994). Am J Kidney Dis 39:1-246, 2002.
613. Hsu CY, Chertow GM. Chronic renal confusion: insufficiency,
failure, dysfunction, or disease. Am J Kidney Dis 39
(Suppl 1) :37-41, 2002.
614. Comité de Registro de la Sociedad de Nefrología y Registros
Autonómicos. Informe de Diálisis y Trasplante de la
Sociedad de Nefrología y Registros Autonómicos, correspondiente
a 1999. Nefrología 21:246-252, 2001.
615. Röhrich B, Asmus G, Von Herrat D, Schaefer K: Is it worth
performing kidney replacement therapy omn patients over
80? Nephrol Dial Transplant 11: 2412-2413, 1996.
616. Delano BG. Regular dialysis treatment . En Drukker W,
Parson FM, Maher JF (Eds). Replacement of renal function by
dialysis. Boston. Martinus Nijhoff, pp 391-409, 1983.
617. Frei U, Schober-Halstenberg HJ and the QuaSi Task Group
for Quality Assurance in Renal Replacement Therapy.
Annual Report of de the German Renal Registry 1998.
Nephrol Dial Transplant 14:1085-1090, 1999.
205